NXC-201 CAR-T

· Nexcella Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NXC-201 CAR-T, covering 2025-07-10 to 2025-07-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis [Phase 1, Phase 2]